TBC’s Alex Ksendzovsky: The Neurosurgeon Using Brain Cells To Build Better AI

12 Jun 2026 · 37 min · 17 chapters

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

Biological Computing Company (TBC) co-founder/CEO Alex Ksendzovsky argues that “biologically-derived algorithms” can improve AI efficiency and quality by encoding data into live neurons grown on multi-electrode arrays, then using decoded neural responses to create learning-rule/software adapters for existing models. The near-term focus is TBC-enhanced open-source video generation (and possibly language/other modalities), with a longer-term goal of real-time biological computing in data centers.

Guest backgrounds

Alex Ksendzovsky is a neurosurgeon and neuroscientist who previously worked in academia at the University of Maryland; his research includes growing neurons on electrodes for epilepsy/disease and using clinical electrode recordings. Co-founder John has a finance background (prior Wall Street) and neuroscience research experience.

Key claims

Neurons in a dish can be kept alive for months (6–12 months), and targeted experiments can yield measurable model gains with minimal parameter increases (e.g., ~27% image reconstruction loss improvement with ~1% adapter parameters; doubled video rollout frames on Oasis). TBC says it’s deriving principles from interacting with neurons (not merely “inspired by” literature).

Notable examples

Encoding MNIST/CIFAR patterns; early “S&P 500 in an Airbnb” dataset idea; improving Oasis video generation (36→64 Minecraft frames); partnerships and upcoming deployment via a “neocloud.”

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Chapters

Tap a time to open that second in VO

Introducing Alex Ksendzovsky

0:45 to 1:20

Discussion on Alex's transition from neurosurgeon to tech entrepreneur.

“how human insight and living brain cells can help power a new generation of AI models and why he thinks the data center of the future just might be alive.”

Understanding Biological Computing

1:20 to 2:14

Exploration of how biological neurons are used to build algorithms.

“So I think the simplest way to think about it is we are building software from wetware.”

Differences Between Inspired and Derived Algorithms

2:14 to 3:57

Explanation of the distinction between brain-inspired and biologically-derived algorithms.

“And what we do is we encode information from the outside world into the biology.”

Alex's Transition into Tech Entrepreneurship

3:57 to 6:16

Alex shares his journey from academia to founding a startup.

“We're building biologically-derived algorithms, right?”

The S&P 500 Experiment

6:16 to 7:28

Alex recounts using neurons to analyze stock market data.

“through neurosurgery, so practicing neurosurgeon, and also a neuroscientist researcher, where I was kind of filling my toolbox to get to this point.”

Decoding Patterns and Predictions

7:28 to 12:30

Discussion on how neurons can identify patterns and make predictions.

“And it just so happens that Silicon Valley, San Francisco is where crazy ideas are born.”

Maintaining Live Neurons for Experiments

12:30 to 14:00

Details on the process of growing and maintaining neurons for research.

“How do you keep them alive so that you can, you know, in a viable way, actually train things off of them?”

Culturing Neurons for AI

14:00 to 16:03

Learn about the process and challenges of maintaining neuron cultures for AI.

“A certain amount of CO2 needs to be maintained.”

Launching TBC: Challenges and Strategies

16:10 to 17:17

Discover the hurdles faced while launching TBC and the strategies employed to convince stakeholders.

“And, you know, that's getting past this kind of continued upstart moment, which is, you know, are these guys a research project versus they're actually building products?”

Investor Pitching Without Data

17:28 to 20:39

Explore the innovative approach to pitching investors despite lacking initial data.

“I assume when you first pitched investors, it wasn't quite this polished, the product you were demonstrating.”
Show all 17 chapters

Key Insights from Early Successes

20:39 to 22:51

Hear about the critical moments that defined the early successes of the startup.

“Is there one moment that comes to mind first?”

Transition from Concept to Product

22:51 to 24:53

Understand the decision-making process behind turning biological computing concepts into marketable products.

“Like, was it more you being practical or was that something that was exciting to you guys early on?”

Performance Improvements in AI Models

24:53 to 28:07

Learn how the team achieved significant improvements in AI model performance through innovative approaches.

“We took a state-of-the-art, smaller video generation model called Oasis.”

The Cost of Neuron-Based AI

28:07 to 30:28

Learn how TBC manages the costs of using living neurons for AI development.

“And how do you do this sustainably, efficiently?”

Ethical Considerations of Biological Computing

30:28 to 32:14

Explore the ethical implications of using neurons in AI and how TBC addresses them.

“People are going to use it because it's either cheaper, it's better quality, or both.”

TBC's Unique Approach in a Nascent Field

32:14 to 35:07

Understand what differentiates TBC in the field of biological computing.

“There was a report last month from Japan using these rat-derived cells.”

The Vision for Real-Time Biological Computing

35:07 to 36:20

Discover TBC's long-term vision for integrating biological networks with AI.

“both of which haven't really had access to the other one's field, that's the moat that we're building.”
Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:00Alex Ksendzovsky:What if I told you that the tech behind the best, cheapest, and fastest image and video models might not come from fancy AI alone, but from the same kinds of cells living inside one of the oldest technologies of all, your brain? It may sound like science fiction, but at the Biological Computing Company, a startup that came out of stealth earlier this year, it's becoming reality. We're not building brain-inspired AI, we're building biologically-derived algorithms, right? And so this is a bit of a stepping stone towards real-time biological computing. but it builds the foundation to get there. This episode is brought to you by Rippling AI, the only AI built to give you full visibility into your startup and the ability to take action across every department.

0:41Alex Ksendzovsky:On this week's episode, we discuss how co-founder and CEO Alex Zanzowski went from neurosurgeon to tech entrepreneur, how human insight and living brain cells can help power a new generation of AI models and why he thinks the data center of the future just might be alive. I'm Alex Conrad, founder and editor of Upstarts Media, And this is the Upstarts Podcast, our weekly show where we talk to emerging startup founders who are punching above their weight and taking on the status quo. Alex, thanks so much for joining the show. Thanks a lot for having me. We've got an Alex Alex pod here in San Francisco today.

1:12Alex Ksendzovsky:What is the biological computing company besides a very sort of intriguing name that I think you guys settled upon after another one? Yeah, yeah. So I think the simplest way to think about it is we are building software from wetware. So what that actually means is we take real biological neurons, so real brain cells, grow them in a dish of electrodes, and we build software tools that emulate how the brain processes information. And so we're creating algorithms that are a lot more efficient and have much better quality. And so you're working with these neurons that are living neurons that can die.

1:45Alex Ksendzovsky:And from them, you are essentially able to create better models that can be used for images and videos, more akin to how we would think of sort of traditional AI software. Exactly, yeah. Yeah, so the product we built itself is algorithms that are more efficient. We're starting with video generation, so the output is much more higher quality, but that can extend to language and other modalities as well. The premise of the company is that the brain processes information in a very special way. It's a lot more efficient in the way it processes it. It's a lot more dynamic and complex. And what we do is we encode information from the outside world into the biology.

2:20We observe how the neurons, the brain cells process that information. We mathematically model that. and build adapters, learning rules that can be incorporated into current AI systems to make them better, faster, cheaper, stronger.

2:34Alex Ksendzovsky:So I know you've only been out of stealth for a couple months. You guys announced a seed round of$25 million. Is this in the market today? Do you have customers? Or just how early are we with TBC? We have a product that's a TBC-enhanced open-source video generation model. We have a partnership which we'll announce in the coming months that's serving this model on a neocloud. And so we're going to ultimately, customers will be able to use it on the marketplace. And so, yeah. And so in the coming months, our product will be deployed and people will be able to use it. So when I first heard about the idea of, you know, neurons helping to train AI, I'm sure my mind, like a lot of people, went to, oh, like, are these neurons in a data center?

3:16Alex Ksendzovsky:Are we going to see racks of like, you know, living GPUs or something like that that are creating a much better output? But that's not quite what's going on here. Can you correct for everyone else the mental image that they might have? So not yet. We're getting there. We're building the foundation to perform what you're suggesting is real-time biological computing. But to get there, it's going to require probably five, ten years, and a lot needs to be figured out. What we realized is in the interim as we're building this foundation, we can really incorporate our findings into current-day AI systems, right?

3:49And so we can make significant strides on transform models, for example. We can build new algorithms that mimic the brain more closely. We're not building brain-inspired AI. We're building biologically-derived algorithms, right? And so this is a bit of a stepping stone towards real-time biological computing, but it builds the foundation to get there.

4:09Alex Ksendzovsky:What is the big difference between inspired and derived? Why is that so important? So there's a lot of interest, it has been, for many years to try to emulate the brain and biology and build algorithms. But everyone stops short at this idea of inspiration. And so, for example, you look at the hippocampus from memory, you look at larger circuits in the brain, ask, okay, well, how does behavior happen from these larger circuits, okay? But there's so many different things that happen. There's so many things that need to be true from a biology perspective to be able to have a behavior occur in the brain.

4:39And so ultimately, other companies have fallen short because they can't actually model, can't actually see what happens in the neurons themselves. So we have this model of neurons in the dish. We can actually interact with them and code information into them, understand how they process that information. And so we're actually deriving these principles rather than just reading the literature like everybody else's and trying to figure out what the important concept is.

5:01Alex Ksendzovsky:Now, you are not originally a Silicon Valley tech founder. You were an academic on the East Coast at the University of Maryland. How did you kind of end up a Silicon Valley entrepreneur from that Baltimore start? I've been obsessed with this idea for over 20 years. I wanted to do this when I was a college student in 2005. I worked in a lab, one of the first labs growing brain cells on electrodes, and immediately thought that we should be using it to predict the stock market. That led me onto this journey. And at the time, I kind of pitched it to my professor, and he said it was a bad idea, and he was right.

5:36Alex Ksendzovsky:What was your goal with that research? Like, were you thinking you were going to become an academic yourself, or were you excited by research? Why had you ended up in that lab in the first place? He came and gave a talk to one of my philosophy classes, and I was just amazed by what he was doing. He was trying to understand how memory works and individual neurons. So I was just amazed by what he was doing, and I just had to gravitate to that lab. Something just brought me there. Within a couple of weeks working there, I started to think about how do you apply real world to these biological cultures rather than just kind of understanding mechanistically how memory, creativity, and other things work.

6:10Like, how do you apply a real application to this? This has been in the back of my mind ever since, but I ended up going to a career in academia through neurosurgery, so practicing neurosurgeon, and also a neuroscientist researcher, where I was kind of filling my toolbox to get to this point. So my research efforts in my lab were growing neurons and electrodes to study epilepsy and disease. Through my clinical practice, I'm the type of neurosurgeon who places electrodes in the brain to try to understand epilepsy. All of these concepts come together and converge in a dish of neurons where we can abstract from the neural signals, just like we do from epilepsy patients.

6:47Keep the cells alive for a long time, just like I had to do in my lab. So my research, my clinical career kind of converged on this 2022 moment where I was like, okay, now the technology exists to do this. And so like you said, we started in Baltimore. My co-founder, John, and I, my best friend, we started another company together. So we had this realization that if you have a really good idea, you don't need to push it through the academic route. You can actually get venture capital. You can actually and get other folks to fund it. And that's when we started the company in 2022. And so it was really born out of this idea that we were obsessed with this concept and it had to exist.

7:24And we were finding the best way to get it out to the world and try to understand it and try to create it. And it just so happens that Silicon Valley, San Francisco is where crazy ideas are born. And so that's how we ended up being entrepreneurs.

7:37Alex Ksendzovsky:You know, I talked to founders who grow up wanting to be an entrepreneur, maybe their parents are small business owners, or maybe they read about startups and they're really excited. Then I also talk to people who become really deep domain experts and to advance their field or to commercialize it, they feel like, oh, I've got to go do this myself as a founder. And they kind of back into entrepreneurship. When you were growing up, were you like, I want to be a doctor? Were you like, oh, startups are cool? What would have been your journey from the lab to the startup? Yeah, I think it's more the latter.

8:11You know, when I was growing up, I wanted to understand the world. I wanted to understand the brain. I wanted to understand what makes us who we are. That led me towards a path of neurosurgery from a clinical perspective of having access to the brain that ultimately led me towards research and neuroscience. You know, as I mentioned in college when I kind of became obsessed with this idea of biological computing, that was a nice route into where we are today, where it's an idea that I feel like I need to solve. John, I need to solve this for the world. And so it was more of an obsession around this concept, and we backed into entrepreneurship that way.

8:46Alex Ksendzovsky:There's a story that I know you've told multiple times where you and your co-founder are in like an Airbnb in Washington trying to get neurons to see a pattern with S &P 500 data. Why were you in this Airbnb? Like, give me some context there. The S &P 500 idea. So this was kind of a nod to, you know, I was a poor college kid. And, you know, the obvious use case at the time of biological compute was to predict the stock market. Like it was like so clear to me. Yeah, like we can, yeah. Obviously, it's not no longer what we're doing right now. But when we decided. Right now. For sure. Well. Maybe someday you'll circle back.

9:24Yeah. But what we landed on when we decided to start the company was we needed a data set. Right. And like, why not? Right. Why not try to, you know, John has a finance background before he went to medical school and did neuroscience research. He was actually on Wall Street. And so we're like, well, we need a data set. Why don't we start to encode S &P 500 values into the dish? You know, when we started the company, we raised a small pre-seed round. So we were, you know, we were looking for lab space. You know, John was an Airbnb. I can't remember why in D.C. at the time. I was in Baltimore. And so we just kind of got a bunch of computers together, started to look at S &P 500 values, trying to understand which data to encode.

9:58ultimately were able to raise enough funds to open up a lab in Baltimore, independent of my other efforts. And that was the first data that we encoded. And so, kind of a bit of a nod back to history. We got some pretty interesting results, honestly. I'm not going to say that we predicted the stock market, but it was pretty cool. We pivoted onto other data sets that made more sense. But yeah, that was the start.

10:19Alex Ksendzovsky:When I heard, okay, they were able to get these neurons to spot a pattern in the market data. My next kind of question, which might be very basic, but, you know, I'm probably not the only one who had it, is what exactly would that pattern look like? Why would that be valuable to anyone besides just like, oh, here's a spike of activity. These neurons fired, you know, at a certain time. Well, it's a prediction. It's a prediction of what happens next. And so think about it, think about intuition. What is intuition in the human brain, right? And so as we're sitting here today, you know, your brain is constantly predicting what the next thing that's going to happen in front of you is.

10:53Similarly to kind of old school stockbrokers when they're staring at charts, you know, the thing that makes a lot of them so good is the intuition and the gut feeling of what to invest in next and when to sell, buy, et cetera, right? And so what actual intuition is, is your brain and the way neurons are firing in relationship to one another, predicting what the future is going to look like. And so that's what's happening in the dish of neurons. So there are patterns that are emerging that we can decode into real world actions. You know, when we were in stealth for the first couple of years, we were really building a language.

11:24And kind of what you're asking is, how do you know what the signals mean? How do you know what the patterns mean? How do you know how to send a pattern to the dish?

11:30Alex Ksendzovsky:Or how did you know that the signals would be valuable? That there would be business insights or model improvements that would actually create a product from that? That was our intuition in a funny way, right? So our intuition is that there's value in this, right? And for the first three years, we had to build a language to encode information and decode, extract that value. And now the whole premise of the company is how do you apply it towards these real-world business use cases? Throughout the first three years, we were getting results that were incredible, showing that we were right, our hypothesis that in an extremely energy-efficient way, you can pull out patterns from this dish of neurons and apply them towards real computational use cases, whether it's prediction or it's classification or now it's building software tools to improve video generation.

12:14There are the special properties of brain cells that we can now extract, model, and apply. And so, yeah, so the whole premise now is now that we have a language to encode information and decode the neural response, now we're applying it and showing significant improvements in video generation.

12:30Alex Ksendzovsky:We're going to talk about that in a sec, but I think first with painting the picture of these neurons, you had done this in your academic labs, you probably knew how, but not a lot of startups are playing with live neurons. Where are these neurons coming from? How do you keep them alive so that you can, you know, in a viable way, actually train things off of them? Like, give us the high level of what that setup looks like. Yeah, so neurons come from either animal brains or rat brains, or we can create them from stem cells that come from human skin cells. And so we have both models. There's advantages and disadvantages to both.

13:02We grow them or maintain them on what's called a multi-electrode array. And so I know you have yours here. Yeah. You're just in the lab.

13:08Alex Ksendzovsky:So we went to the lab this morning. We got a tour, and I got this souvenir. And what are we looking at here? So this is the multi-electrode array. So this is where we maintain the cells. And right in the middle of this dish is our 4 ,096 electrodes. And I keep referring to electrodes, and I don't want to go too off topic here, but just to tell the audience why it's important. Right now what's happening in your brain as you're listening to this, as you're watching this podcast, is the light waves, the sound waves, are being converted to electrical signals in your brain. That's how your brain understands and creates images, sounds, et cetera.

13:40When you don't have those senses in a dish, you need to communicate with the neurons somehow, and that's through electrical signals. And that's why it's important for them to live on these electrodes. So, painting the picture for you, as you asked earlier, we take brain cells from rats. We create brain cells out of stem cells. We keep them in a perfect environment. And so, they're at body temperature 37 degrees. A certain amount of CO2 needs to be maintained. They live in a pink media. That pink media maintains sugars, amino acids for them to live. They do produce waste, just like any other living cells.

14:13And that has to be removed. So we pipette new media in or new food in and remove the waste every couple of days. And so there's a process to it. I mean, you have to take care of them and maintain them. They live for many months, so six months to a year at this point. But to get here, it required massive optimization. And so just a Quick aside in terms of, you know, academic world versus the startup or industry, our biology team is maintaining the neural cultures. Everything is aimed towards how do you make them live longer? How do you get the perfect culture? How do you get improved cell viabilities?

14:44And so over the years, with an incredible team, we've been able to do that. And so they live for, like I said, many months. We can do many targeted experiments in terms of encoding data, pulling out these, extracting these software adapters for our algorithms. And so we've been able to scale at this point.

14:59Alex Ksendzovsky:Now, you'd already trained to become a neurosurgeon. You were doing academia. These are not easy career choices. Was launching the company hard in its own way or was it relatively straightforward compared to all the work you had done to get to that point? When you think about sort of what were the hardest moments here, where does just launching TBC stack up? It was about as straightforward as this, right? It was not easy and still not easy, right? I mean, we're bringing something completely crazy to the world, right? And we're showing that it works, right? And we're still battling with this. One of the hardest things is convincing people that this is not a research project, that this is production ready.

15:39We have models built off of our biologically derived concepts that are better, right? That have better evals, better benchmarks. And we have to convince the world, right? I think that what we're doing is so unique that there's a lot of interest, but there's also a lot of scrutiny, which I enjoy. I think it needs to be that way. And so to get around that, a big part of our launch was a blog that we put out. And I encourage everybody, go to tbc.co.com because that's our data. And we will continue to update it. We want people to look at it. We want people to understand it. And, you know, that's getting past this kind of continued upstart moment, which is, you know, are these guys a research project versus they're actually building products?

16:22Like I said, in the coming months, we will be deploying our first TPC enhanced video generation model. And so I think that will certainly help. But yeah, that was, I think, the challenge that we've been overcoming for the last couple of years.

16:35Alex Ksendzovsky:These days, you can chat with AI about almost any business problem. Rippling AI is built to actually solve them. That's because Rippling AI is built on your live workforce data. That gives you full visibility into your startup and the ability to take action across every department. Say you're planning your next few hires. Just ask Rippling AI, what would it cost to add two more engineers this quarter? You'll instantly see a breakdown of comp ranges by level and location. So you can make the smartest hiring decision based on where your team has gaps and where the talent is. But it doesn't stop there.

17:07Alex Ksendzovsky:Rippling AI can draft the job wrecks, route them for approval, and kick off the hiring workflow. All you have to do is tap confirm and then get back to building. Don't settle for AI that's all talk. Head to rippling.ai slash upstarts and get AI that turns insights into action. That's R-I-P-P-L-I-N-G dot AI slash upstarts. Sign up for exclusive access today. I assume when you first pitched investors, it wasn't quite this polished, the product you were demonstrating. Was it relatively easy to get at least some weird investors on board right away? Or was there a breakthrough or like a key demonstration that you guys had to nail for, you know, investors to give you money to start hiring people?

17:51So we actually pitched with no data. No data? No, yeah, because we needed separation from an IP perspective from any laboratory and obviously the way we, or any institution, right? And so obviously the way we obtain data is through growing neurons. And so we pitched with no data, but we had a great plan. John and I have the background to do this. Shout out to Refactor Capital, Zoll, Better Call Zoll, invested in us, believed in us, along with Wonder Ventures and some other great investors for the pre-seed round. And yeah, it kind of kicked us off to get the results. Let me restate that.

18:28Alex Ksendzovsky:Okay. It kind of kicked us off to get the data and results to ultimately raise the seed round from primary. Got it. And at the time that Primary invests, you get the$25 million, now you have data to show you can do the demonstration or some version of it of what you did for me today? Well, yeah, yeah. So the Pre-Seed was an investment that allowed us to really build out a lab, build this language to encode information. So we had tons and tons of data coming in. You know, the thing that kind of transitioned us into the investment from Primary was actually a use case, right? So we went from this idea of, okay, we built this language to encode information, but now what do we use it for?

19:05And so we talked a little bit about the classification of MNIST and CIFAR and the data that we also have on the blog. And so there was very clear at that point that we can build computational tools. We can incorporate this into AI algorithms and improve them. And so that was what led into the seed round. And so certainly now we have capital to come to San Francisco, build out the team, deploy this to customers, which will lead itself. into the next fundraising round.

19:32Alex Ksendzovsky:When you were trying to hire that team, you're competing against, you know, the leading AI labs in the world here in San Francisco, a bunch of other cool startups. Were you selling people on like neurons? Like it's alive, like loving the sci-fi part of this or just the practical work that they could be doing? Like, hey, you get to be in this lab or you get to be playing with the models. What was like the pitch that resonated with those, you know, early hires? I think this is the coolest job in Silicon Valley in the country. I mean, I think that our AI researchers are able to really, this is really the bleeding edge, right?

Read the full transcript

20:06You want to meet the group. Everyone is very mission-driven, right? Everyone believes in this, and they see the value. And so we are competing against the other labs, right? But we're the only ones that are doing this. And so I don't want to say it's easy. I mean, nothing's ever easy. But, you know, we haven't had a very difficult time hiring folks because it's so unique and so interesting what we're doing.

20:26Alex Ksendzovsky:When you think about the moment where you were most kind of punching above your weight so far, where you're like, you know, I can't believe this worked or that was great, but let's not do that again. We call it on the show sort of an upstart moment. Obviously, I feel a lot of them as a year old startup. Is there one moment that comes to mind first? I think for me, the moment was when I realized that this works and that now that this works, that was the inflection point in me to change my career completely. and similar for John. When we realized this works, it was the inflection point for us to go from academic neurosurgeons to startup founders.

21:01And that was the first data set that we encoded, which was handwritten numbers, MNIST. It was a bit of a nod to the original convolutional neural network data. And so ultimately, when we figured out how to encode that into the dish, figured out how to decode the neural response, and we showed that the classification is better, that was the first time anyone's applied this vague concept of biological and computing to a real-world use case. And that was the aha moment for us. I was like, oh, crap, this works. And now we have to really build it. Was it exciting? Was it scary? Both, right? It was awesome, right?

21:33I mean, to have realized something that we've been thinking about for a long time into something real. But then the harrowing thought of what comes next was both exciting and scary at the same time.

21:47Alex Ksendzovsky:You said you did one other startup, at least briefly. Was that in a completely different area or what framework did that get? Completely different area. And it's awesome. It's a company called NeuroPM. It was an algorithm on the Apple Watch to track Parkinson's disease. We were involved from a clinical perspective, helping to build a product, got it past the FDA. And when we started this company, we stepped back to focus on this full time. And you had a different name initially that was maybe a little too opaque. What was the original name of the company? We started as Biological Black Box. This is a little sensitive subject to me because I really liked that name that a lot of people didn't.

22:21But I think I'm very happy with what we settle on now because I think it's much more obvious what we're doing. Some of the feedback we got for the first name was, are you building black boxes to put on airplanes? And people kept thinking of airplanes going down. It was all this imagery we didn't want. And so we sunset that name. But ultimately, with our new name, it's obvious what we're doing. And like I said, we want to be on the forefront of building this new category of biological computing, which is what we're doing.

22:51Alex Ksendzovsky:Was the decision to productize models that could compete with, you know, leading image and video model providers out there, was that a more practical one of like, hey, this is how we can make money and actually ship a product in the short term because that maybe really crazy future of the neurons in the data center is a 10-year horizon? Like, was it more you being practical or was that something that was exciting to you guys early on? A little bit of both. I mean, like I said, I think that we can drive, you know, we're all about driving impact, right? And we can drive a lot of impact by incorporating this into software, right?

23:27The practical component of it was the data set we used. And so the way we ended up in video generation and image generation was from the first data sets that we started to play with in terms of MNIST and CIFAR, so within computer vision. So from that perspective, it made sense for us to move on to the more state-of-the-art models, which is video generation. I think that certainly showing that we can create revenue, showing that we can create products is much more of a practical approach than hoping that happens in 10 years. But again, I don't want to understate the impact that it has because if you look at our blog, we're showing in the blog twofold increase in video generation rollout or how much video is created.

24:10In data that we have now, it's at least four to five X that. And so, again, these are massive gains that can be applied across advertisement, across robotics, across a lot of different industries. It can have significant impact. And so, calling this practical, I think, is a bit of a misnomer because it's still creating algorithms from brain cells. But I guess it's a little bit more practical than data centers with neurons in them.

24:36Alex Ksendzovsky:I love despite how different our startups are, we both live and die by getting people to check out our blog. I salute you for your dedication to getting people to both of our blogs. I do think it is important that you show people that because you are trying to be transparent that these models actually are better, right? So can you talk a little bit about where you've been able to do head-to-head comparisons, where you have seen noticeable improvements, and what level of improvement you've already achieved? We took a state-of-the-art, smaller video generation model called Oasis. It's open source.

25:09It's published online. as a toy model to say, okay, can we improve this? Can we do better on metrics like video rollout or the amount of resolution an image or video has when it comes out? And so we did that. And so we built it. And so kind of a quick insight into how we do things, we have what's called our algorithm discovery platform. And the idea there is we take a state-of-the-art model, we build it in the cloud, we benchmark it, understand it, understand its limitations. This is where our AI team says, okay, we can only get X number of frames of rollout or et cetera, et cetera, right? We then go to the neuroscience team and say, okay, well, what neuroscience principles and literature is there that support how the brain does this?

25:47And this is, as I mentioned earlier, where most or all other labs that are inspired by neuroscience stop. We then go to the dish of neurons and we perform very targeted experiments that ask questions of how are images or videos represented in the dish and the neurons, for example. We then mathematically model that in our loop and we put it back through software adapters or learning rules into the AI system, into the algorithm, diffusion transform more, for example, and then we re-benchmark it. And if it did better, great, we continue to explore it. If it didn't, then we fail fast and we kind of punted to the side that concept.

26:18And so we did this with Oasis, and this is what's on our blog. We showed that we can have at least a 27 % improvement in image reconstruction loss. So it's CRISPR by about 27%. But the important part is it's 27%, but the adapter is only 1 % increase in parameters. So we're also always thinking about quality versus compute, right? Because if we double the size of the model, that's not very, you know, or 27, you know, increase it significantly, that's not very practical, right? And so what we showed was we had, you know, a 27-fold efficiency gain. For only 1 % increase in parameters, we can have a significant improvement in image reconstruction.

26:56Similarly, with a very lightweight adapter, we also improved video rollout. So we doubled that. And so what that means is if you're generating 36 frames, for example, with Oasis, it's trained on Minecraft, so 36 Minecraft frames. We were able to get it into 64 with our very first adapter. Again, that's published in the blog. Soon to be published in the blog is many fold that, right?

27:18Alex Ksendzovsky:I am going to have to turn off your mic if you say your blog one more time at this point. We will soon show location unknown. Mysterious. even more improvements on that as we build our adapters and improve our process even more. And so, you know, we'll publish this soon to come, but what you'll see that we'll deploy to customers is a much larger model that has even significant improvements in video rollout and improvements, things like state persistence and memory improvements and things like the physical representations of objects. And so that'll be what's coming out, and it'll be benchmarked against the state of the art.

27:57Alex Ksendzovsky:For people who are trying to understand how this is economically an unlock or viable, who pays for this right now? And how do you do this sustainably, efficiently? When we've had folks on the show who are spending hundreds of millions of dollars in AI training various things, is that the scale you're operating at? Or is it cheaper to have a neuron? Most people don't have any pet living neurons in their home. Maintaining our wet lab and maintaining the neurons is actually quite cheap. It's on the order of tens to hundreds of thousands per year, not what these other labs run. Where we spend most of our money is on the compute side, because we are constantly improving and building these algorithms, but also why we started with and play around with smaller toy models that are smaller parameter count.

28:50The customer, as we said, is other businesses, folks that are interested in generating video So advertisement companies, for example, that go to the open marketplace and find the cheapest model they can do this with, that has the best quality. And so what we offer and what people will see soon is a model that outperforms state of the art that doesn't cost quite as much per token to use. And so that's who's going to pay for it. Certainly we have a lot of other efforts underway in terms of improving our adapters, improving the models we build in-house, scaling to other models as well outside of the video generation models that we have now.

29:29And so that's paid for by our awesome investors.

29:33Alex Ksendzovsky:But one thing that I just find kind of interesting is that in the short term, you were sort of living or dying as a startup by these models being valuable to people and better bang for the buck, regardless of whether we are excited by the neuron narrative or sort of how they're derived at all, right? Like just in a vacuum, I see this model does well. I want to pay for it. I don't need the whole backstory of the neurons. But then behind the scenes, you can be continuously improving these models with the neurons. You can be kind of keeping the whole flywheel spinning because of the neurons. But they're sort of like the secret sauce behind the scenes for now, right?

30:12Yeah. You know, we had an investor once tell us, don't even tell people you're using neurons. You know, just hide that. Don't tell people that. Like I said, I think that that is a secret sauce, right? And I think that it makes us unique, but the proof is in the pudding, right? People aren't going to use it just because it comes from neurons. People are going to use it because it's either cheaper, it's better quality, or both. And so, yeah, I mean, we have to, in our products, show the world that they're useful. People will use them if they are, right? And there's the added benefit of the story where they came from, which is very personal, meaning the brain.

30:43Alex Ksendzovsky:Totally. And that sauce or pudding, whichever metaphor we want to use, is a kind of funky one because it is these neurons that are, you know, you showed me, it's almost like a film, pinkish, you know, and it does feel very like sci-fi in real life. As that gets more and more advanced, do you wonder about ethical implications of like, you know, these networks of neurons have memory or they start to have other lifelike functions where maybe you need like an on-staff bioethicist or something? Or how do you think about sort of the frontier ethics that come into play here? Yeah, no, thanks for that question.

31:18And we talk about this a lot. We think about this a lot. And we interface with bioethicists a lot on this. Just to be very clear, you know, what we have in the dish is never, not sentient, never going to be sentient. Does not feel pain. Does not have any of the things that humans, animals, et cetera, have. It's a tiny, tiny fraction of the brain, what we have in there. They're neurons. Not only is it a tiny fraction, we also remove all the connections from them and reconnect them to serve our purpose, right? There's no blood vessels. There's no three-dimensional architecture to them, right? If you think of what has to happen for you to have the emerging properties in your brain, like consciousness, awareness, sentience, pain, et cetera, it's so different than what we have in the dish that it's never going to get to that point.

31:59And as we continue to drive this technology, we have very clear guardrails of not getting to that point and making sure it doesn't. So, yeah. So, you know, we are definitely working with bioethicists, and we think about this a lot. And we've set up the guardrails to make sure we don't get to that point.

32:13Alex Ksendzovsky:And so I've seen there's a couple other research projects out there. There was a report last month from Japan using these rat-derived cells. There's another project going on at Princeton with stem cells. And there's a couple other companies taking other approaches here. What would you say is the most different piece of what TBC is doing or where maybe you guys are most unique in this admittedly quite small and nascent field just to begin with? Yeah, so first and foremost, you know, I want to call out the fact that it's awesome. There are other people thinking aligned in their thinking of biological computing.

32:46We're trying to create a category, right? And so I think the more academic interest, the more industry interest there is in this, the better. And so it's a pie that everyone should be growing. What we're building that nobody else is, is the application layer for this. So rather than going to this real-time compute kind of scenario with data centers, with chips in them, which, like I said, is relatively far away from a research perspective, we're building the application layer for this. What do you apply neurons to? And so right now, it's better software. And as far as I know, no one else is thinking this way, no one else is doing.

33:17I'm sure as people see podcasts like this, as people kind of read about us, they'll be also interested, which I encourage. There's so much to do at this point. We're kind of like where computers were punch cards, right, in terms of this category. And there's so much to do, but there's so much that can be done.

33:37Alex Ksendzovsky:Not a lot of people, of course, have access to these neurons. Like we literally scrubbed up to go look at this culture. And so you could show me a demonstration in the lab today. So in that sense, I feel like you have a natural moat. But on the flip side, you are competing with other approaches to chips, other approaches to these video and image models. Do you worry about kind of how do we keep justifying that we are better than these other approaches? Or have you just always been confident that this is such a fundamentally more efficient way to do things that we should always have an advantage?

34:08It's so fundamentally different. I have about 500 million years of evidence behind me. And so if you look at the 70 years of development in silicon systems compared to what we can accomplish with our brain in terms of how much data is required, how much energy. A cheese sandwich. I didn't have a cheese sandwich, but that has fueled me for this conversation, right?

34:28Alex Ksendzovsky:It would have also fueled the rat model more than the human model probably for the cheese. Sorry, that's the dumbest thing I can say. But continue, yeah. It took me a second to get that. Yeah, your neurons started firing. Yeah, you saw the delay, right? That's why real-time compute isn't now. Yeah, so I've got hundreds of millions of years of evidence that suggests that there's something special in the system, right? And so our moat is evolution, but also it's the institutional knowledge that we've maintained as a company. I've been doing this for a long time. John and I have been doing this for a long time.

34:59But our AI researchers, our neuroscientists, we have 25 people now, our biologists, have now been doing this for a couple of years, right? And so every day when I walk in, when I see one of my AI researchers on the whiteboard with a neuroscientist coming up with completely innovative techniques, both of which haven't really had access to the other one's field, that's the moat that we're building. It's the institutional knowledge across all of our researchers, all of our employees that have been building something new together that I think is going to be very difficult to replicate even on a larger scale.

35:32Alex Ksendzovsky:So obviously, a couple months into the public journey, you're out there telling everyone what's possible today. When you think about what's possible 10 years from now and what winning would look like for TBC, what is the big picture vision? Yeah, I mean, I think the pie in the sky, the North Star is real-time biological computing, where we're actually plugging biological networks or neurons into data centers for real-time inference, for things like intuition, for a personalized AI that's constantly learning, just like the brain does. So that's the vision. Like I said earlier, we're building the foundation for that now.

36:06So it's certainly not something that's possible today, but with the tools that we're building on the way to improving software and AI systems, we're learning more and more towards realizing this world of real-time biological computing.

36:19Alex Ksendzovsky:And so is the dream that someday you're a software leader and making kind of cool next-gen hardware out there too? Well, yeah. I mean, in order for us to test our next-gen hardware, we need a model to test it on, right? And so the models that we're building now, the software layer that we're building now, is what we're going to use to test our biological hardware in the future. And so if you want to separate them, fine. But in reality, the software tools we're building today will be enhanced even further by real-time biological compute. And so that's kind of the roadmap. Awesome. Well, thanks for coming on the show, Alex.

36:51Alex Ksendzovsky:Awesome. Thanks a lot for having me.

37:01You

From the publisher

Ever since neurosurgeon Alex Ksendzovsky was in college, he’s been captivated by an idea worthy of a mad scientist: turning brain cell ‘wetware’ into ‘software’ that can make predictions and help train AI.

It sounds like science fiction, but at Ksenzovsky’s startup The Biological Computing Co., or TBC, the founder swears it’s already reality. A model improved with algorithms derived from a process that involves connecting a dish of neurons to tiny electrodes demonstrated a 27-fold efficiency gain.

“I have about 500 million years of evidence behind me,” Ksendzovsky says. “So our moat is evolution.”

Investors have poured more than $25 million into the project. But at least one told Ksendzovsky to leave the neurons out of their pitch, for now. He won’t listen.

“We’re bringing something completely crazy to the world, and we’re showing that it works,” Ksendzovsky says.

On The Upstarts Podcast, we discuss why algorithms derived by actual brain cells beat traditional ones only inspired by the brain; the ethics of using living neurons for training AI models; and a possible living data center future.

Plus, Ksendzovksy shares his Upstart Moment: giving up, alongside his neurosurgeon co-founder, promising careers in academia to pursue a startup.

CHAPTERS
00:00 Introduction
01:12 Building software from wetware
05:09 A college idea to predict the stock market
08:40 The first test from an Airbnb
12:46 Rat neurons and electrodes
17:30 Pitching VCs with no data
24:52 Promising early AI results
31:09 The ethics of using neurons
34:40 ‘Our moat is evolution’
35:38 A real-time biological computing future

For more, visit ⁠⁠⁠https://www.upstartsmedia.com/⁠⁠⁠

Season 2 of the Upstarts Podcast is presented by ⁠⁠⁠Rippling⁠⁠

Produced & edited by Eric Johnson from ⁠⁠⁠LightningPod

More from The Upstarts Podcast

All 23 episodes
TBC’s Alex Ksendzovsky: The Neurosurgeon Using Brain Cells To Build Better AIThe Upstarts Podcast · 37 min
Listen in VO